Targeted therapies and survival: what we can learn from studies in advanced renal cell carcinoma

Oncology. 2013;84(1):39-42. doi: 10.1159/000342768. Epub 2012 Oct 17.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Renal Cell / drug therapy
  • Carcinoma, Renal Cell / metabolism
  • Carcinoma, Renal Cell / mortality*
  • Humans
  • Kidney Neoplasms / drug therapy
  • Kidney Neoplasms / metabolism
  • Kidney Neoplasms / mortality*
  • Molecular Targeted Therapy*
  • Neoplasm Proteins / antagonists & inhibitors*
  • Neoplasm Proteins / metabolism
  • Prognosis
  • Survival Rate

Substances

  • Antineoplastic Agents
  • Neoplasm Proteins